Analysis Of Income And Expense [Abstract]

Xspray Pharma - Filing #702829

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
- SEK
- SEK
Material income and expense [abstract]
Research and development expense
38 567 SEK
6 549 SEK
Finance income (cost)
1 255 SEK
1 047 SEK
Selling, general and administrative expense [abstract]
Selling, general and administrative expense
58 384 SEK
47 101 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- SEK
- SEK
- SEK
96 698 SEK
96 698 SEK
52 410 SEK
- SEK
52 410 SEK
- SEK
- SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.